WSU-DLCL2, a human diffuse large cell lymphoma cell line, is a mature B-cell line (IgG l) that is negative for EBV nuclear antigen, expresses the multi-drug resistance phenotype, and has t (14;18) (q32;q21) plus other chromosomal aberrations.